BriaCell Therapeutics Corp. (8BT)

Profile

https://briacell.com

BriaCell Therapeutics Corp. is a clinical-stage biotechnology company focused on developing targeted immunotherapies for cancer. BriaCell Therapeutics Corp. is best known for its cell-based oncology programs, including Bria-IMT, a lead therapy being studied for metastatic breast cancer, along with Bria-OTS, a personalized off-the-shelf immunotherapy platform, and Bria-PROS+ for prostate cancer. The company also works on BriaDx, a diagnostic tool designed to support patient selection for its immunotherapy approaches. Its current business centers on advancing cancer treatment candidates through clinical development, with an emphasis on breast cancer and other solid tumors. Based in West Vancouver, Canada, BriaCell Therapeutics Corp. operates within the immuno-oncology segment of the healthcare market, where it develops novel therapeutic and diagnostic assets aimed at improving how cancer is detected and treated.